Cargando…

Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006

BACKGROUND: Few longitudinal cohort studies have focused on the impact of substances abused and psychiatric disorders on premature mortality. The aim of the present study was to identify predictors of increased risk of drug related death and non drug related death in substance abusers of opiates, st...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyhlén, Anna, Fridell, Mats, Bäckström, Martin, Hesse, Morten, Krantz, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163521/
https://www.ncbi.nlm.nih.gov/pubmed/21801441
http://dx.doi.org/10.1186/1471-244X-11-122
_version_ 1782210952959098880
author Nyhlén, Anna
Fridell, Mats
Bäckström, Martin
Hesse, Morten
Krantz, Peter
author_facet Nyhlén, Anna
Fridell, Mats
Bäckström, Martin
Hesse, Morten
Krantz, Peter
author_sort Nyhlén, Anna
collection PubMed
description BACKGROUND: Few longitudinal cohort studies have focused on the impact of substances abused and psychiatric disorders on premature mortality. The aim of the present study was to identify predictors of increased risk of drug related death and non drug related death in substance abusers of opiates, stimulants, cannabis, sedatives/hypnotics, hallucinogens and alcohol over several decades. METHODS: Follow-up study of a consecutive cohort of 561 substance abusers, admitted to a detoxification unit January 1970 to February 1978 in southern Sweden, and followed up in 2006. Demographic and clinical data, substance diagnoses and three groups of psychiatric diagnoses were identified at first admission. Causes of death were coded according to ICD-10 and classified as drug related deaths or non drug related deaths. To identify the incidence of some probable risk factors of drug related premature death, the data were subjected to a competing risks Cox regression analysis. RESULTS: Of 561 patients in the cohort, 11 individuals had either emigrated or could not be located, and 204/561 patients (36.4%) were deceased by 2006. The cumulative risk of drug related death increased more in the first 15 years and leveled out later on when non drug related causes of death had a similar incidence. In the final model, male gender, regular use of opiates or barbiturates at first admission, and neurosis were associated with an increased risk of drug related premature death, while cannabis use and psychosis were associated with a decreased risk. Neurosis, mainly depression and/or anxiety disorders, predicted drug related premature death while chronic psychosis and personality disorders did not. Chronic alcohol addiction was associated with increased risk of non drug related death. CONCLUSIONS: The cohort of drug abusers had an increased risk of premature death to the age of 69. Drug related premature death was predicted by male gender, the use of opiates or barbiturates and depression and anxiety disorders at first admission. The predicted cumulative incidence of drug related death was significantly higher in opiate and barbiturate abusers over the observed period of 37 years, while stimulant abuse did not have any impact. Alcohol contributed to non drug related death.
format Online
Article
Text
id pubmed-3163521
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31635212011-08-30 Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006 Nyhlén, Anna Fridell, Mats Bäckström, Martin Hesse, Morten Krantz, Peter BMC Psychiatry Research Article BACKGROUND: Few longitudinal cohort studies have focused on the impact of substances abused and psychiatric disorders on premature mortality. The aim of the present study was to identify predictors of increased risk of drug related death and non drug related death in substance abusers of opiates, stimulants, cannabis, sedatives/hypnotics, hallucinogens and alcohol over several decades. METHODS: Follow-up study of a consecutive cohort of 561 substance abusers, admitted to a detoxification unit January 1970 to February 1978 in southern Sweden, and followed up in 2006. Demographic and clinical data, substance diagnoses and three groups of psychiatric diagnoses were identified at first admission. Causes of death were coded according to ICD-10 and classified as drug related deaths or non drug related deaths. To identify the incidence of some probable risk factors of drug related premature death, the data were subjected to a competing risks Cox regression analysis. RESULTS: Of 561 patients in the cohort, 11 individuals had either emigrated or could not be located, and 204/561 patients (36.4%) were deceased by 2006. The cumulative risk of drug related death increased more in the first 15 years and leveled out later on when non drug related causes of death had a similar incidence. In the final model, male gender, regular use of opiates or barbiturates at first admission, and neurosis were associated with an increased risk of drug related premature death, while cannabis use and psychosis were associated with a decreased risk. Neurosis, mainly depression and/or anxiety disorders, predicted drug related premature death while chronic psychosis and personality disorders did not. Chronic alcohol addiction was associated with increased risk of non drug related death. CONCLUSIONS: The cohort of drug abusers had an increased risk of premature death to the age of 69. Drug related premature death was predicted by male gender, the use of opiates or barbiturates and depression and anxiety disorders at first admission. The predicted cumulative incidence of drug related death was significantly higher in opiate and barbiturate abusers over the observed period of 37 years, while stimulant abuse did not have any impact. Alcohol contributed to non drug related death. BioMed Central 2011-07-30 /pmc/articles/PMC3163521/ /pubmed/21801441 http://dx.doi.org/10.1186/1471-244X-11-122 Text en Copyright ©2011 Nyhlén et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nyhlén, Anna
Fridell, Mats
Bäckström, Martin
Hesse, Morten
Krantz, Peter
Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
title Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
title_full Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
title_fullStr Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
title_full_unstemmed Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
title_short Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
title_sort substance abuse and psychiatric co-morbidity as predictors of premature mortality in swedish drug abusers a prospective longitudinal study 1970 - 2006
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163521/
https://www.ncbi.nlm.nih.gov/pubmed/21801441
http://dx.doi.org/10.1186/1471-244X-11-122
work_keys_str_mv AT nyhlenanna substanceabuseandpsychiatriccomorbidityaspredictorsofprematuremortalityinswedishdrugabusersaprospectivelongitudinalstudy19702006
AT fridellmats substanceabuseandpsychiatriccomorbidityaspredictorsofprematuremortalityinswedishdrugabusersaprospectivelongitudinalstudy19702006
AT backstrommartin substanceabuseandpsychiatriccomorbidityaspredictorsofprematuremortalityinswedishdrugabusersaprospectivelongitudinalstudy19702006
AT hessemorten substanceabuseandpsychiatriccomorbidityaspredictorsofprematuremortalityinswedishdrugabusersaprospectivelongitudinalstudy19702006
AT krantzpeter substanceabuseandpsychiatriccomorbidityaspredictorsofprematuremortalityinswedishdrugabusersaprospectivelongitudinalstudy19702006